Kesimpta (Ofatumumab)

New Topic

12 topics • Page 1 of 1

Topics

Replies

Views

Last post

Kesimpta prescribing information

Last post by NHE « Fri Aug 21, 2020 5:43 pm

by NHE » Fri Aug 21, 2020 5:43 pm

Kesimpta prescribing information.

0 Replies

173 Views

Last post by NHE
Fri Aug 21, 2020 5:43 pm
Ofatumumab vs. Teriflunomide in Multiple Sclerosis, Phase III Trials

Last post by NHE « Sat Aug 22, 2020 4:18 am

by NHE » Sat Aug 22, 2020 4:18 am

Ofatumumab versus Teriflunomide in Multiple Sclerosis
N Engl J Med. 2020 Aug 6;383(6):546-557.

Background: Ofatumumab, a subcutaneous anti-CD20...

0 Replies

498 Views

Last post by NHE
Sat Aug 22, 2020 4:18 am
Ofatumumab Phase IIb Trial, MIRROR Study

Last post by NHE « Sat Aug 22, 2020 4:05 am

by NHE » Sat Aug 22, 2020 4:05 am

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
Neurology. 2018 May 15;90(20):e1805-e1814....

0 Replies

241 Views

Last post by NHE
Sat Aug 22, 2020 4:05 am
FDA approves Kesimpta (ofatumumab)

Last post by NHE « Thu Aug 20, 2020 3:32 pm
Replies: 1
by NHE » Thu Aug 20, 2020 3:27 pm

First post

Kesimpta is a patient SC injectable anti CD20 monoclonal antibody version of Ocrevus. It's poduced by Novartis in partnership with Genmab A/S....

Last post

There's more info on Kesimpta at

1 Replies

231 Views

Last post by NHE
Thu Aug 20, 2020 3:32 pm
Drug company gives ofatumumab update

Last post by MSUK « Wed Mar 09, 2016 2:59 am

by MSUK » Wed Mar 09, 2016 2:59 am

Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis...

0 Replies

1096 Views

Last post by MSUK
Wed Mar 09, 2016 2:59 am
Positive top-line phase II results of Ofatumumab in MS

Last post by MSUK « Fri Oct 11, 2013 2:31 am

by MSUK » Fri Oct 11, 2013 2:31 am

Genmab A/S announced top-line results from a Phase II study of the subcutaneous formulation of
ofatumumab in relapsing-remitting multiple sclerosis...

0 Replies

1903 Views

Last post by MSUK
Fri Oct 11, 2013 2:31 am
Glaxo and Genmab drop IV version of MS immune drug

Last post by MSUK « Thu Sep 16, 2010 10:32 pm

by MSUK » Thu Sep 16, 2010 10:32 pm

GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and...

0 Replies

1426 Views

Last post by MSUK
Thu Sep 16, 2010 10:32 pm
Genmab announces results of Ofatumumab phase II study in MS

Last post by MSUK « Mon Sep 13, 2010 1:27 am

by MSUK » Mon Sep 13, 2010 1:27 am

Genmab announces 48 week results from a Phase II study of ofatumumabin RRMS.

Genmab A/S announced encouraging results from an ofatumumab Phase II...

0 Replies

1603 Views

Last post by MSUK
Mon Sep 13, 2010 1:27 am
Ofatumumab Phase II

Last post by scorpion « Fri Sep 10, 2010 10:30 am

by scorpion » Fri Sep 10, 2010 10:30 am

Sounds good so far.

0 Replies

2186 Views

Last post by scorpion
Fri Sep 10, 2010 10:30 am
Interim results of Ofatumumab phase II study in MS announced

Last post by MSUK « Wed Jul 07, 2010 5:02 am

by MSUK » Wed Jul 07, 2010 5:02 am

Genmab A/S announced today positive interim results from an ofatumumab Phase II safety and pharmacokinetics study in patients with...

0 Replies

1483 Views

Last post by MSUK
Wed Jul 07, 2010 5:02 am
Genmab Announces Interim Results of Ofatumumab Phase II Stud

Last post by scorpion « Tue Jul 06, 2010 11:50 am

by scorpion » Tue Jul 06, 2010 11:50 am

0 Replies

2003 Views

Last post by scorpion
Tue Jul 06, 2010 11:50 am
Ofatumumab

Last post by bromley « Mon Jun 30, 2008 10:48 am

by bromley » Mon Jun 30, 2008 10:48 am

Tiny update on ofatumumab

0 Replies

1942 Views

Last post by bromley
Mon Jun 30, 2008 10:48 am

New Topic

12 topics • Page 1 of 1

Return to Board Index

Forum permissions

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum